Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease.

"CONFLICT OF INTEREST STATEMENT C.E.C., I.A.L., N.A.D.P., O.L., C.C., D.F., L.F., C.J., M.L., S.La., C.L., J.-C.A. and S.Li. declare no conflict of interest. Z.A.M. reports having received grants for CKD-REIN and other research projects from Amgen, Baxter, Fresenius Medical Care, GlaxoSmithKline, Merck Sharp & Dohme-Chibret, Sanofi- Genzyme, Lilly, Otsuka, AstraZeneca, Vifor and the French government, as well as fees and grants to charities from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline. The sponsors had no role in the design, execution, interpretation, or writing of the study."

"CONFLICT OF INTEREST STATEMENT: C.E.C., I.A.L., N.A.D.P., O.L., C.C., D.F., L.F., C.J., M.L., S.La., C.L., J.-C.A. and S.Li. declare no conflict of interest. Z.A.M. reports having received grants for CKD-REIN and other research projects from Amgen, Baxter, Fresenius Medical Care, GlaxoSmithKline, Merck Sharp & Dohme-Chibret, Sanofi- Genzyme, Lilly, Otsuka, AstraZeneca, Vifor and the French government, as well as fees and grants to charities from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline. The sponsors had no role in the design, execution, interpretation, or writing of the study."